Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Bipolar II Disorder
Interventions
BEHAVIORAL

Interpersonal and Social Rhythm Therapy (IPSRT-BPII)

"IPSRT is comprised of three components: psychoeducation, social rhythm therapy, and standard IPT as developed for unipolar depression.~Psychoeducation focuses on a) the illness and its consequences, b) treatment options and associated side effects, and c) prodromal symptoms/detection of early warning symptoms."

DRUG

Seroquel

"Subjects will be started at 100 mg/day titrated to a maximum of 800 mg /day~Day 1-BID doses totaling 100 mg/day, increased to 400 mg/day on Day 4 in increments of up to 100 mg/day in BID divided doses, by Day 6 begin titration up to a maximum dose of 800 mg/day in increments no greater than 200 mg/day.~This titration schedule may be adjusted based on the subject's response and ability to tolerate Seroquel.~Subjects who are unable to tolerate the study medications, or for whom the study medications are an inappropriate clinical choice, will be treated openly by a clinic physician according to the standard of care guidelines designated by the American Psychiatric Association (2002) for the treatment of bipolar disorder."

Trial Locations (1)

15213

University of Pittsburgh /University of Pittsburgh Medical Center (UPMC), Pittsburgh

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

University of Pittsburgh

OTHER

NCT00411463 - Psychotherapy for Bipolar II Depression, Pilot Study, Phase II | Biotech Hunter | Biotech Hunter